| Bioactivity | STAT3-IN-36 (compound 11g) is a triple-target inhibitor targeting LRPPRC, STAT3, and CDK1 with anticancer activity. STAT3-IN-36 binds to LRPPRC, STAT3, and CDK1, exerting a stronger anticancer effect than TMF (HY-N6818) or Capecitabine (HY-B0016). STAT3-IN-36 inhibits HGC27 cells with IC50 1.8 μM. |
| CAS | 3055766-74-7 |
| Formula | C30H24F2N2O9S2 |
| Molar Mass | 658.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
STAT3-IN-36
CAS: 3055766-74-7 F: C30H24F2N2O9S2 W: 658.65
STAT3-IN-36 (compound 11g) is a triple-target inhibitor targeting LRPPRC, STAT3, and CDK1 with anticancer activity. STAT
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.